EUVIMEDEUVIMED entdecken
Open Access

Elevated Systemic Levels of Markers Reflecting Intestinal Barrier Dysfunction and Inflammasome Activation Are Correlated in Severe Mental Illness

Søren B Jensen, Mashhood A Sheikh, Ibrahim A Akkouh, Attila Szabo, Kevin S O'Connell, Tove Lekva, John A Engh, Ingrid Agartz, Torbjørn Elvsåshagen, Monica B E G Ormerod, Melissa A Weibell, Erik Johnsen und 11 weitere

Schizophrenia Bulletin · 03.05.2023 · 49 (3) · 635-645

DOI: 10.1093/schbul/sbac191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Schizophrenia Bulletin, online erschienen am 03.12.2022. Verfasst von Søren B Jensen und 22 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Inflammasomes, Schizophrenia. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: South East Norway Health Authority.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Hypothesis Gut microbiota alterations have been reported in severe mental illness (SMI) but fewer studies have probed for signs of gut barrier disruption and inflammation. We hypothesized that gut leakage of microbial products due to intestinal inflammation could contribute to systemic inflammasome activation in SMI. Study Design We measured plasma levels of the chemokine CCL25 and soluble mucosal vascular addressin cell adhesion molecule-1 (sMAdCAM-1) as markers of T cell homing, adhesion and inflammation in the gut, lipopolysaccharide binding protein (LBP) and intestinal fatty acid binding protein (I-FABP) as markers of bacterial translocation and gut barrier dysfunction, in a large SMI cohort (n = 567) including schizophrenia (SCZ, n = 389) and affective disorder (AFF, n = 178), relative to healthy controls (HC, n = 418). We assessed associations with plasma IL-18 and IL-18BPa and leukocyte mRNA expression of NLRP3 and NLRC4 as markers of inflammasome activation. Study Results Our main findings were: (1) higher levels of sMAdCAM-1 (P = .002), I-FABP (P = 7.6E−11), CCL25 (P = 9.6E−05) and LBP (P = 2.6E−04) in SMI compared to HC in age, sex, BMI, CRP and freezer storage time adjusted analysis; (2) the highest levels of sMAdCAM-1 and CCL25 (both P = 2.6E−04) were observed in SCZ and I-FABP (P = 2.5E−10) and LBP (3) in AFF; and (3), I-FABP correlated with IL-18BPa levels and LBP correlated with NLRC4. Conclusions Our findings support that intestinal barrier inflammation and dysfunction in SMI could contribute to systemic inflammation through inflammasome activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InflammasomesSchizophreniaHumansInflammation

Stichwörter der Autor:innen

affective disorderinflammasomeintestinal fatty acid binding proteinlipopolysaccharide binding proteinmucosal vascular addressin cell adhesion molecule-1schizophrenia

Substanzen

Inflammasomes

Autor:innen und Institutionen

  • Research Institute of Internal Medicine, Oslo University Hospital, Oslo, Norway.
  • Division of Mental Health and Addiction, Norwegian Centre for Mental Disorders Research, NORMENT, Oslo University Hospital, Oslo, Norway.
  • Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
  • K.G. Jebsen Center for Neurodevelopmental disorders, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Division of Mental health and Addiction, Vestfold Hospital Trust, Tønsberg, Norway.
  • Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet and Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.

Förderung

  • South East Norway Health Authority

Zitieren

APA

Jensen, S. B., Sheikh, M. A., Akkouh, I. A., Szabo, A., O'Connell, K. S., Lekva, T., Engh, J. A., Agartz, I., Elvsåshagen, T., Ormerod, M. B. E. G., Weibell, M. A., Johnsen, E., Kroken, R. A., Melle, I., Drange, O. K., Nærland, T., Vaaler, A. E., Westlye, L. T., Aukrust, P., …, & Ueland, T. (2023). Elevated Systemic Levels of Markers Reflecting Intestinal Barrier Dysfunction and Inflammasome Activation Are Correlated in Severe Mental Illness. Schizophrenia Bulletin, 49(3), 635-645. https://doi.org/10.1093/schbul/sbac191

Vancouver

Jensen SB, Sheikh MA, Akkouh IA, Szabo A, O'Connell KS, Lekva T, et al. Elevated Systemic Levels of Markers Reflecting Intestinal Barrier Dysfunction and Inflammasome Activation Are Correlated in Severe Mental Illness. Schizophrenia Bulletin. 2023;49(3):635-645. doi:10.1093/schbul/sbac191

BibTeX
@article{Jensen2023,
  author = {Jensen, Søren B and Sheikh, Mashhood A and Akkouh, Ibrahim A and Szabo, Attila and O'Connell, Kevin S and Lekva, Tove and Engh, John A and Agartz, Ingrid and Elvsåshagen, Torbjørn and Ormerod, Monica B E G and Weibell, Melissa A and Johnsen, Erik and Kroken, Rune A and Melle, Ingrid and Drange, Ole K and Nærland, Terje and Vaaler, Arne E and Westlye, Lars T and Aukrust, Pål and Djurovic, Srdjan and Eiel Steen, Nils and Andreassen, Ole A and Ueland, Thor},
  title = {Elevated Systemic Levels of Markers Reflecting Intestinal Barrier Dysfunction and Inflammasome Activation Are Correlated in Severe Mental Illness},
  journal = {Schizophrenia Bulletin},
  year = {2023},
  volume = {49},
  number = {3},
  pages = {635--645},
  doi = {10.1093/schbul/sbac191}
}
Kostenlos starten →